Neurocrine Biosciences reported $11.56B in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Acorda Therapeutics ACOR:US USD 7M 1000K
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Amgen AMGN:US USD 120.36B 9.61B
Aptinyx Inc APTX:US USD 25M 13M
Biogen BIIB:US USD 39.1B 9.24B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Cytokinetics CYTK:US USD 4.56B 1.2B
Dynavax Technologies DVAX:US USD 1.32B 270M
Enanta Pharmaceuticals ENTA:US USD 1.08B 96M
Exelixis EXEL:US USD 5.05B 1.63B
Gilead Sciences GILD:US USD 77.36B 170M
Halozyme Therapeutics HALO:US USD 5.45B 622M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Intra Cellular Therapies ITCI:US USD 4.41B 977M
Nektar Therapeutics NKTR:US USD 600M 108M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Pfizer PFE:US USD 245.6B 48.58B
Prothena PRTA:US USD 2.84B 1.57B
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Repligen RGEN:US USD 10.38B 1.38B
Rigel Pharmaceuticals RIGL:US USD 204M 10M
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Teva Pharmaceutical TEVA:IT USD 30.77B 1.12B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
Xoma XOMA:US USD 205M 50M
YTE INCY:US USD 14.82B 2.01B